Avid Bioservices is a contract development and manufacturing organization that provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing, focused on biopharmaceutical drug substances derived from mammalian cell culture. Co. produces monoclonal antibodies and recombinant proteins, and its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. Co. also provides process development services, including upstream and downstream development, analytical method development, testing and characterization. The CDMO stock yearly return is shown above.
The yearly return on the CDMO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CDMO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|